Back
Alnylam Pharmaceuticals Stock Predictions
Sponsored
ALNY
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23
ALNY
Alnylam Pharmaceuticals
Last Price:
244.97
Seasonality Move:
11.66%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Alnylam Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 37.8% based on the past 20 years of stock performance.
- Alnylam Pharmaceuticals has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
-
Is Alnylam Pharmaceuticals Stock Undervalued?
The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal. - ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 37.8% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
23
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
- Alnylam Pharmaceuticals has risen higher in 13 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 65%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
141.98
Prediction Charts
Market Cap:
31.59B
Price in USD:
244.89
Volume:
516.28K
Beta:
1.20
Technical Analysis
SMA50:
272.49
SMA100:
265.22
SMA200:
211.63
52-Wk Change:
50.35%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?
Yes, Alnylam Pharmaceuticals is a publicly traded company. -
What is the Alnylam Pharmaceuticals stock quote today?
The Alnylam Pharmaceuticals stock price is 244.89 USD today. -
How to buy Alnylam Pharmaceuticals stock online?
You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-5 | 268.47 | 265.29 | 268.89 | 264.23 |
Nov-6 | 266.21 | 273.00 | 278.21 | 265.52 |
Nov-7 | 273.01 | 272.22 | 275.07 | 270.04 |
Nov-8 | 271.63 | 277.43 | 279.51 | 270.98 |
Nov-11 | 276.10 | 279.82 | 286.58 | 276.10 |
Nov-12 | 268.22 | 268.95 | 270.77 | 264.11 |
Nov-13 | 269.20 | 264.47 | 271.08 | 264.31 |
Nov-14 | 262.18 | 257.91 | 262.83 | 256.75 |
Nov-15 | 253.11 | 235.56 | 254.17 | 234.88 |
Nov-18 | 235.80 | 232.27 | 242.49 | 229.86 |
Nov-19 | 232.19 | 234.27 | 235.94 | 231.23 |
Nov-20 | 235.78 | 248.79 | 249.10 | 234.43 |
Nov-21 | 247.46 | 246.80 | 250.71 | 245.32 |
Nov-22 | 248.90 | 244.89 | 248.90 | 243.35 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.